Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 2Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3

Conditions

Carcinoma, Non-Small-Cell Lung 3Breast Neoplasms 3Ovarian Neoplasms 2Lung Neoplasms 2Carcinoma, Ovarian Epithelial 2Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Neuroendocrine Tumors 1Fallopian Tube Neoplasms 1Carcinoma, Small Cell 1

Interventions

Trastuzumab 243Paclitaxel 193Cyclophosphamide 158Docetaxel 134Letrozole 113Capecitabine 113Fulvestrant 106Doxorubicin 103Bevacizumab 87Carboplatin 81exemestane 80Anastrozole 79Lapatinib 70Tamoxifen 69Albumin-Bound Paclitaxel 57palbociclib 54pertuzumab 53Taxes 51Gemcitabine 50Radiotherapy 46eribulin 43pembrolizumab 41Everolimus 41Ado-Trastuzumab Emtansine 41Vinorelbine 38130-nm albumin-bound paclitaxel 35ixabepilone 32Epirubicin 28pegfilgrastim 25liposomal doxorubicin 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Has results × Breast Neoplasms × taxane × Clear all
NCT04293393 2026-03-12

CARABELA

Spanish Breast Cancer Research Group

Phase 2 Active not recruiting
200 enrolled 27 charts
Breast

Breast Neoplasms

NCT01446016 2023-01-23

CAT

The Methodist Hospital Research Institute

Phase 2 Completed
38 enrolled 11 charts
Breast

Breast Neoplasms

NCT00475670 2014-09-15

A Study of Herceptin (Trastuzumab) in Women With Metastatic Breast Cancer

Hoffmann-La Roche

Phase 2 Completed
44 enrolled 15 charts
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡